In these cases, omissions or errors in the medication order may lead to dispensing from the wrong drug supply at the time orders are filled. Lastly, in the investigational study setting ...

Pharmaceutical companies often have a limited supply of an investigational drug, which may not be sufficient to meet the demand from both clinical trials and EAPs. 4 This raises difficult ...

The supply chain requires transporting cold goods, such as meat and dairy. What about medical products? Vaccines, insulin, and other medications require cold chain logistics. Industry professionals ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Researchers discover new insights into how dual-target drug may supercharge cancer-fighting immune cells. Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, which is a new investigational drug for cannabis withdrawal syndrome. If approved ...

Patents issued for investigational drugs last only 20 years ... Assay development and the initiation of centralized clinical trial supply can delay trial start up, while required medical ...

"We are now, within short, ready to initiate the phase 2b study - with the goal of making fostrox + Lenvima the first approved medical treatment for second-line liver cancer" October - DecemberFinanci ...

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Ideaya Biosciences (IDYA) announced it has entered into an additional clinical study collaboration and supply agreement with Gilead Sciences ...